These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11704693)
41. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test. Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704 [TBL] [Abstract][Full Text] [Related]
42. Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease. Han Y; Jia J; Jia XF; Qin W; Wang S Neurosci Lett; 2012 May; 516(2):232-6. PubMed ID: 22503901 [TBL] [Abstract][Full Text] [Related]
43. Can clock drawing differentiate Alzheimer's disease from other dementias? Tan LP; Herrmann N; Mainland BJ; Shulman K Int Psychogeriatr; 2015 Oct; 27(10):1649-60. PubMed ID: 26138809 [TBL] [Abstract][Full Text] [Related]
44. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Allan LM; Ballard CG; Burn DJ; Kenny RA J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166 [TBL] [Abstract][Full Text] [Related]
45. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Adair JC; Charlie J; Dencoff JE; Kaye JA; Quinn JF; Camicioli RM; Stetler-Stevenson WG; Rosenberg GA Stroke; 2004 Jun; 35(6):e159-62. PubMed ID: 15105518 [TBL] [Abstract][Full Text] [Related]
46. Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis. Misciagna S; Masullo C; Giordano A; Silveri MC Int J Neurosci; 2005 Dec; 115(12):1657-67. PubMed ID: 16287632 [TBL] [Abstract][Full Text] [Related]
47. Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease. Chan M; Lim WS; Sahadevan S Dement Geriatr Cogn Disord; 2008; 26(6):513-21. PubMed ID: 19052451 [TBL] [Abstract][Full Text] [Related]
48. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia. Engelborghs S; Le Bastard N J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896 [TBL] [Abstract][Full Text] [Related]
49. Visual association memory test in differentiating early stage of Alzheimer's disease from vascular dementia. Chuang WL; Wang HM; Hsieh YC; Chang TF; Kuo HC; Huang CC Acta Neurol Taiwan; 2006 Jun; 15(2):98-104. PubMed ID: 16871896 [TBL] [Abstract][Full Text] [Related]
50. GH response to GH-releasing hormone (GHRH) in Alzheimer and vascular dementia. Relation with somatostatin cerebrospinal levels. Gómez IM; Aguilar M; Navarro MA; Ortolà J; Soler J Ann Endocrinol (Paris); 1996; 57(2):107-10. PubMed ID: 8881289 [TBL] [Abstract][Full Text] [Related]
51. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia. Traykov L; Baudic S; Raoux N; Latour F; Rieu D; Smagghe A; Rigaud AS J Neurol Sci; 2005 Mar; 229-230():75-9. PubMed ID: 15760623 [TBL] [Abstract][Full Text] [Related]
52. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Fredman P; Wallin A; Blennow K; Davidsson P; Gottfries CG; Svennerholm L Acta Neurol Scand; 1992 Feb; 85(2):103-6. PubMed ID: 1574982 [TBL] [Abstract][Full Text] [Related]
53. N-Terminal Prosomatostatin and Risk of Vascular Dementia. Holm H; Nägga K; Nilsson ED; Ricci F; Cinosi E; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A Cerebrovasc Dis; 2017; 44(5-6):259-265. PubMed ID: 28854435 [TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Llorens F; Hermann P; Villar-Piqué A; Diaz-Lucena D; Nägga K; Hansson O; Santana I; Schmitz M; Schmidt C; Varges D; Goebel S; Dumurgier J; Zetterberg H; Blennow K; Paquet C; Baldeiras I; Ferrer I; Zerr I Nat Commun; 2020 Jan; 11(1):619. PubMed ID: 32001681 [TBL] [Abstract][Full Text] [Related]
55. Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia. Olsson B; Hertze J; Lautner R; Zetterberg H; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Blennow K; Hansson O J Alzheimers Dis; 2013; 33(1):45-53. PubMed ID: 22890100 [TBL] [Abstract][Full Text] [Related]
56. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease. Park JH; Lee SB; Lee TJ; Lee DY; Jhoo JH; Youn JC; Choo IH; Choi EA; Jeong JW; Choe JY; Woo JI; Kim KW Dement Geriatr Cogn Disord; 2007; 23(2):67-73. PubMed ID: 17114882 [TBL] [Abstract][Full Text] [Related]
57. Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen project. Aguero-Torres H; Kivipelto M; von Strauss E Dement Geriatr Cogn Disord; 2006; 22(3):244-9. PubMed ID: 16902279 [TBL] [Abstract][Full Text] [Related]
58. Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Haglund M; Sjöbeck M; Englund E Dement Geriatr Cogn Disord; 2004; 18(2):132-7. PubMed ID: 15211067 [TBL] [Abstract][Full Text] [Related]
59. Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease. Dhoat S; Ali K; Bulpitt CJ; Rajkumar C Age Ageing; 2008 Nov; 37(6):653-9. PubMed ID: 18703522 [TBL] [Abstract][Full Text] [Related]
60. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. Bruandet A; Richard F; Bombois S; Maurage CA; Deramecourt V; Lebert F; Amouyel P; Pasquier F J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):133-9. PubMed ID: 18977819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]